# Older Adults Turn to Cannabis Primarily for Symptom Management > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/older-adults-turn-to-cannabis-primarily-for-symptom-management/ > **Published:** 2026-05-21T11:22:50-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:54:34-04:00 > **Clinical Summary:** Older adults increasingly use cannabis for symptom management. Clinical guidance on safety, interactions, and evidence-based dosing for geriatric patients. --- ✦ New CED Clinical Relevance #71 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. AgingPainSleepAnxietyResearchSafetyMental Health Why This Matters Clinicians need to understand that older adults are increasingly self-treating with [cannabis for pain](https://cedclinic.com/cannabis-veterans-substance-use-disorder-study/), sleep, and anxiety rather than consulting healthcare providers, which creates gaps in medical supervision and drug interaction monitoring. This shift toward [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) in seniors demands that primary care physicians routinely screen older patients for [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) and discuss evidence-based alternatives, potential risks including falls and cognitive effects, and drug interactions with their existing medications. Without this clinical engagement, older adults may abandon proven treatments or combine cannabis with pharmaceuticals in ways that compromise safety and therapeutic outcomes. Clinical Summary A recent JAMA Network Open study examining [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) patterns in older adults found that the majority use cannabis primarily for symptom management rather than recreational purposes, viewing it as an effective alternative to conventional pharmaceuticals. This finding reflects a significant shift in how seniors perceive cannabis, particularly as an option for managing [chronic pain](https://cedclinic.com/cannabinoids-pain-management-opioid-alternative/), sleep disturbance, and other age-related conditions where traditional medications may carry undesirable side effects or drug interactions. The research highlights that older adults often initiate cannabis use after exhausting conventional treatment options, suggesting they view it as a pragmatic adjunctive or [alternative therapy](https://cedclinic.com/cannabis-for-chronic-pelvic-pain-self-management/). From a clinical perspective, these results underscore the need for physicians to engage in informed, non-judgmental conversations about cannabis use with older patients, especially those managing multiple chronic conditions and polypharmacy. Understanding that older adults are using cannabis strategically for symptom relief rather than recreation can help clinicians better assess patient motivation, counsel on efficacy and safety concerns specific to aging populations, and identify potential drug interactions. Clinicians should routinely ask older patients about cannabis use during medication reviews and be prepared to discuss evidence-based information about its benefits and risks in this vulnerable population. Dr. Caplan’s Take “What I’m seeing in my practice aligns with this data: older patients are using cannabis pragmatically to manage pain, sleep, and anxiety where conventional medications either aren’t working or are creating unacceptable side effects, and they’re often doing it without telling their physicians because they’re still uncertain about the medical establishment’s perspective. We need to close that communication gap, because without a proper clinical history, we can’t assess drug interactions, optimize dosing, or monitor for adverse effects in a population that’s already on multiple medications.” Clinical Perspective As cannabis use among older adults increases, clinicians should recognize that this population is motivated primarily by symptom relief rather than recreational effects, often seeking alternatives to conventional medications or perceiving lower risk from plant-based products. However, this preference for cannabis must be contextualized against age-related pharmacokinetic changes, polypharmacy concerns, and limited robust evidence for efficacy in geriatric populations, alongside potential harms including cognitive effects, falls, and drug interactions that may be particularly consequential in older adults. The lack of standardization in cannabis products and dosing, combined with variable state regulations and clinician discomfort discussing the topic, creates a gap between patient use and medical oversight. Rather than dismissing older adults’ interest in cannabis, clinicians should engage in non-judgmental discussions about specific symptoms being treated, current medication regimens, and realistic evidence for benefit, while documenting use and monitoring for adverse effects to ensure safer integration into 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/medical-illness/) Have thoughts on this? Share it: [X Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Older%20Adults%20Turn%20to%20Cannabis%20Primarily%20for%20Symptom%20Management%20%40drcaplan&url=https%3A%2F%2Fcedclinic.com%2F%3Fp%3D55908)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fcedclinic.com%2F%3Fp%3D55908)[🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Older%20Adults%20Turn%20to%20Cannabis%20Primarily%20for%20Symptom%20Management%20via%20%40drcaplan.bsky.social%20https%3A%2F%2Fcedclinic.com%2F%3Fp%3D55908)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan)[📝 Read more on Substack](https://doctorapprovedcannabis.substack.com/)[🔔 Subscribe via RSS](https://cedclinic.com/feed/) Related Articles - [Why older adults are turning to cannabis edibles – @theU – The University of Utah](https://cedclinic.com/why-older-adults-are-turning-to-cannabis-edibles-theu-the-university-of-utah/) - [Older Adults Turn to Cannabis Primarily for Symptom Management – Neurology Advisor](https://cedclinic.com/older-adults-turn-to-cannabis-primarily-for-symptom-management-neurology-advisor/) - [Older Adults Turn to Cannabis Primarily for Symptom Management – MPR – eMPR.com](https://cedclinic.com/older-adults-turn-to-cannabis-primarily-for-symptom-management-mpr-empr-com/) 📰 Source: [https://www.infectiousdiseaseadvisor.com/news/older-adults-turn-to-cannabis-primarily-for-symptom-management/](https://www.infectiousdiseaseadvisor.com/news/older-adults-turn-to-cannabis-primarily-for-symptom-management/) Further Reading Cannabis Policy Wire[Schedules of Controlled Substances: Placement of MDMB-4en-PINACA in Schedule I](https://cedclinic.com/mdmb-4en-pinaca-schedule-i-placement/) CED Clinic Blog[Fear of recurrence, secondary cancers, and health problems in long-term survivors of childhood cancer: Findings from a Canadian cohort.](https://cedclinic.com/fear-of-recurrence-secondary-cancers-and-health-problems-in-long-term-survi/) CED Clinic Blog[Associations of cannabis use, other substances, and lifestyle choices on anxiety in medical cannabis patients across 45 days.](https://cedclinic.com/associations-of-cannabis-use-other-substances-and-lifestyle-choices-on-anxi/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).